AGP Picks
View all

Get your fresh news on health and wellness in New Hampshire

Provided by AGP

New Hampshire Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.

Press releases published on May 14, 2026

Kyverna Therapeutics to Present at Upcoming Investor Conferences
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Forward Therapeutics Announces Completion of Phase 1 Trials with Two Internally Discovered Next-Generation TNF Signaling Inhibitors Supporting Advancement to Phase 2 Clinical Development
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy
Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301
Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction
IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
Brain Cancer Canada Invests $75,000 in Groundbreaking Phase 2 Clinical Trial at Sunnybrook Health Sciences Centre to Target Hard-to-Treat Glioblastoma in Older Patients
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy
SELLAS Life Sciences to Participate in Upcoming Investor Conferences
Synergy CHC Corp. Reports First Quarter 2026 Financial Results
Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M
Legal Steroids for Beginners 2026: (Muscle Growth And Fat Loss) Crazy Bulk Launched Safest Legal Steroid Alternatives Without Side Effects In USA.
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer

Share us

on your social networks:

Sign up for:

New Hampshire Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.